Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Juno Therapeutics
Biotech
Indapta snags $50M and signs on former Juno exec as CEO
Indapta raised more than $50 million in series A financing and has tapped former Juno Therapeutics exec Mark Frohlich, M.D., to be its new CEO.
Max Bayer
Feb 10, 2022 7:30am
Poseida shares plunge after death in solid tumor CAR-T trial
Aug 18, 2020 7:15am
Natural killer biotech Artiva launches with $78M
Jun 26, 2020 8:30am
Juno-lite Sana raises $700M
Jun 23, 2020 8:15am
Juno-WuXi AppTec JV JW Therapeutics nabs $100M for cell therapy
Jun 11, 2020 8:05am
FDA delays decision on approval of Bristol Myers' CAR-T
May 6, 2020 8:10am